Cited by 76Curcumin's Biomedical ApplicationsDrug Solubulity and Delivery SystemsAdvancements in Transdermal Drug Delivery

Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells

Open access
Kumar, Anil, Ahuja, Alka, Ali, Javed, Baboota, Sanjula·2016·Drug Delivery

Abstract

OBJECTIVE: In the present study, Curcumin (CU)-loaded nanocarrier (NC) such as nanoemulsion (NE) was developed with the objective of increasing its cytotoxicity and bioavailability through lymphatic transport by enhancing its solubility and intestinal permeability. MATERIALS AND METHODS: Based on the area obtained in pseudoternary phase diagram, various % combination of Labrafac Lipophile WL 1349, Solutol HS 15, Transcutol HP and distilled water were selected. Formulations which passed physical stability studies were selected for further studies such as globule size, zeta potential, in vitro release, ex vivo permeation, in vitro lipolysis studies, bioavailability studies and cytotoxicity against glioblastoma cells (U-87). RESULT AND DISCUSSION: The optimized NC (NE-SB1) had small average globule diameter of 67 ± 6 nm with zeta potential of -37 ± 2.5 mv which indicated long-term dispersion stability. During in vitro lipolysis study, the digestion rate of medium chain triglycerides increased with decreased globule diameter. Statistically significant difference was found in AUC0-inf of NC formulation (p < 0.05) compared to CU suspension. The relative bioavailability of NC was found 11.88 ± 0.47 with respect to CU suspension. During cytotoxicity studies, IC50 of CU solution on U87 cells was found 24.23 µM, while for the NE- SB1 it was 16.41 µM. The optimized formulation was found to be stable during 6 months of accelerated stability. CONCLUSION: The overall results revealed that the CU-loaded NC is a very effective approach for enhancing the oral absorption of poorly water-soluble drug CU and have great potential for future clinical application.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/10717544.2014.909906

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nanocarriers and nanotechnology could potentially enhance clinical efficacy and therapeutic response.

    “Nonetheless, numerous studies have attempted to improve bioavailability by employing nanocarriers and nanotechnology, which could potentially enhance clinical efficacy and therapeutic response [205].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Aggarwal BB, Surh YJ, Shishodia S. (2007). The molecular target and therapeutic uses of curcumin in health and disease. Advances in experimental medicine and biology series, Vol. 595. New York (NY): Springer, 1-66.

Cited by

Sorted by citations

Authors
Kumar, A., Ahuja, A., Ali, J., & Baboota, S.
Affiliations
  • Jamia Hamdard (IN)
  • Oman Medical College (OM)
Corresponding author
Baboota, Sanjula
Venue
Drug Delivery
Published
2014-05-14
Volume
23
Issue
1
Pages
214-229
ISSN
  • 1071-7544 (ISSN-L)
  • 1521-0464
OpenAlex
W2061498899
Cited by
76
References
30
Citations by year
2026: 2 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 5 · 2019: 13 · 2018: 7 · 2017: 1 · 2016: 8 · 2015: 3 · 2014: 1
FWCI
1.98
Type
journal article
Language
en
Open access
Locations
  • Drug Delivery (publishedVersion)
  • PubMed (publishedVersion)
Funders
All-India Institute of Medical Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
curcumin, nanoemulsions, bioavailability enhancement, oral bioavailability, glioblastoma, U87 cells, cytotoxicity, lymphatic transport, intestinal permeability, lipolysis, poorly water-soluble drugs, drug stability
MeSH terms
Animals, Antineoplastic Agents, Phytogenic, Biological Availability, Brain Neoplasms, Chemistry, Pharmaceutical, Curcumin, Drug Carriers, Drug Stability, Glioblastoma, Humans, Intestinal Absorption, Lipolysis, Particle Size, Triglycerides, Rats, Wistar, Cell Line, Tumor, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review